Tetraphase Pharmaceuticals Reports Second Quarter 2019 Financial Results and Highlights Recent Corporate Developments
XERAVA Sales Grew 133% Compared with First Quarter of 2019 Increased Formulary Uptake, with a 99.7% Success Rate for all…
Pharmaceuticals, Biotechnology and Life Sciences
XERAVA Sales Grew 133% Compared with First Quarter of 2019 Increased Formulary Uptake, with a 99.7% Success Rate for all…
— Targeting Topline Data from STRIDE 3 by the End of 2019 — WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today…
Updated 12-month Phase 3 Data will Serve as the Basis for Submission of the BLA On Track for Anticipated Initiation…
– Phase 1b Bivalent Norovirus Study Fully Enrolled – – Research Collaboration with Janssen for Universal Flu Vaccine Underway –…
HENDERSON, Nev.–(BUSINESS WIRE)–Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, announced today financial…
California certified Golden Grain under the LCFS using Edeniq’s Intellulose 2.0 corn fiber technology VISALIA, Calif.–(BUSINESS WIRE)–#biofuels–Edeniq, Inc. (“Edeniq”), a…
The annual program recognizes 30 exceptional pharmacy professionals in 10 categories CRANBURY, N.J.–(BUSINESS WIRE)–#NextGenPharm—Pharmacy Times®, the leading multimedia pharmacy network,…
DUBLIN–(BUSINESS WIRE)–The “Degenerative Disc Disease – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Degenerative Disc…
DUBLIN–(BUSINESS WIRE)–The “Left Ventricular Dysfunction – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Left Ventricular…
DUBLIN–(BUSINESS WIRE)–The “Restless Legs Syndrome – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Restless Legs…